These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1511002

  • 1. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen.
    Litzinger DC, Huang L.
    Biochim Biophys Acta; 1992 Aug 19; 1127(3):249-54. PubMed ID: 1511002
    [Abstract] [Full Text] [Related]

  • 2. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L.
    Biochim Biophys Acta; 1991 Feb 25; 1062(2):142-8. PubMed ID: 2004104
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
    Litzinger DC, Huang L.
    Biochim Biophys Acta; 1992 Feb 17; 1104(1):179-87. PubMed ID: 1550846
    [Abstract] [Full Text] [Related]

  • 6. Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight.
    Vertut-Doï A, Ishiwata H, Miyajima K.
    Biochim Biophys Acta; 1996 Jan 12; 1278(1):19-28. PubMed ID: 8611602
    [Abstract] [Full Text] [Related]

  • 7. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo.
    Mori A, Klibanov AL, Torchilin VP, Huang L.
    FEBS Lett; 1991 Jun 24; 284(2):263-6. PubMed ID: 2060647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
    Woodle MC, Matthay KK, Newman MS, Hidayat JE, Collins LR, Redemann C, Martin FJ, Papahadjopoulos D.
    Biochim Biophys Acta; 1992 Apr 13; 1105(2):193-200. PubMed ID: 1586658
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A.
    Park YS, Huang L.
    J Drug Target; 1993 Apr 13; 1(4):325-30. PubMed ID: 8069575
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles.
    Parr MJ, Ansell SM, Choi LS, Cullis PR.
    Biochim Biophys Acta; 1994 Oct 12; 1195(1):21-30. PubMed ID: 7918562
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):185-94. PubMed ID: 9735159
    [Abstract] [Full Text] [Related]

  • 17. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits.
    Awasthi VD, Garcia D, Goins BA, Phillips WT.
    Int J Pharm; 2003 Mar 06; 253(1-2):121-32. PubMed ID: 12593943
    [Abstract] [Full Text] [Related]

  • 18. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K, Sundaresan A, Cheow WS.
    Eur J Pharm Biopharm; 2013 Nov 06; 85(3 Pt A):427-43. PubMed ID: 23872180
    [Abstract] [Full Text] [Related]

  • 19. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
    Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A.
    Biochim Biophys Acta; 1991 Jul 01; 1066(1):29-36. PubMed ID: 2065067
    [Abstract] [Full Text] [Related]

  • 20. Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids.
    Holland JW, Cullis PR, Madden TD.
    Biochemistry; 1996 Feb 27; 35(8):2610-7. PubMed ID: 8611564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.